HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An-Ping Lin Selected Research

An-Ping Lin Research Topics

Disease

6Neoplasms (Cancer)
01/2018 - 05/2012
3Lymphoma (Lymphomas)
01/2022 - 03/2016
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 08/2013
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 05/2012
1Hypoxia (Hypoxemia)
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018

Drug/Important Bio-Agent (IBA)

4Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2022 - 03/2016
3Cyclic AMP (AMP, Cyclic)IBA
01/2022 - 03/2016
3RoflumilastIBA
01/2018 - 03/2016
3Phosphodiesterase 4 InhibitorsIBA
01/2018 - 03/2016
2Phosphotransferases (Kinase)IBA
01/2018 - 03/2017
2EnzymesIBA
03/2016 - 07/2015
1Oxygen (Dioxygen)IBA
01/2022
1CytokinesIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2018
1idelalisibIBA
01/2018
1Prednisone (Sone)FDA LinkGeneric
03/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2016
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
03/2016
1DioxygenasesIBA
07/2015
1NucleotidesIBA
08/2013
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
08/2013
1MicroRNAs (MicroRNA)IBA
05/2012